Variant position: 218 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 492 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human LLQCIVLPFCPESPRFLLIN RNEENRAKSVLKKLRGTADVT
Mouse LLQCILLPFCPESPRFLLIN RNEENRAKSVLKKLRGTADVT
Rat LLQCILLPFCPESPRFLLIN RNEENRAKSVLKKLRGTADVT
Pig LLQCVLLPFCPESPRFLLIN RNEENRAKSVLKKLRGTADVT
Bovine LLQCILLPFCPESPRFLLIN RNEENRAKSVLKKLRGTADVT
Rabbit LLQCIVLPLCPESPRFLLIN RNEENRAKSVLKKLRGNADVT
Sheep LLQCILLPFCPESPRFLLIN RNEENRAKSVLKKLRGTADVT
Chicken LLQCIILPFAPESPRFLLIN RNEENKAKSVLKKLRGTTDVS
Drosophila ILQLILLPVCPESPRYLLIT KQWEEEARKALRRLRASGSVE
Baker's yeast LKQLRKYS--PDAKIFVLLH K--------------------
Fission yeast LEATVANS--PQARVFCLIH K--------------------
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
1 – 492 Solute carrier family 2, facilitated glucose transporter member 1
207 – 271 Cytoplasmic
226 – 226 Phosphoserine; by PKC/PRKCB
204 – 204 L -> C. Abolishes glucose transport.
205 – 205 P -> C. Abolishes glucose transport.
226 – 226 S -> A. Abolishes phosphorylation by PKA, leading to impaired response to TPA.
216 – 218
Glucose transporter 1 deficiency in the idiopathic generalized epilepsies.
Arsov T.; Mullen S.A.; Rogers S.; Phillips A.M.; Lawrence K.M.; Damiano J.A.; Goldberg-Stern H.; Afawi Z.; Kivity S.; Trager C.; Petrou S.; Berkovic S.F.; Scheffer I.E.;
Ann. Neurol. 72:807-815(2012)
Cited for: VARIANTS EIG12 HIS-51; MET-60; THR-77; ALA-149; SER-218; GLN-223; VAL-243; SER-411 AND TRP-458; CHARACTERIZATION OF VARIANTS EIG12 MET-60; THR-77; SER-218; GLN-223; VAL-243; SER-411 AND TRP-458;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.